A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is characterised by lung cysts and airflow obstruction. Matrix metalloproteinases have been implicated in lung destruction in LAM. We performed a randomised, double-blind trial, comparing the matrix metalloproteinases inhibitor doxycycline with placebo on the progressi...

Full description

Bibliographic Details
Main Authors: Chang, William Y.C., Cane, Jennifer L., Kumaran, Maruti, Lewis, Sarah, Tattersfield, Anne E., Johnson, Simon R.
Format: Article
Published: European Respiratory Society 2014
Subjects:
Online Access:https://eprints.nottingham.ac.uk/31531/

Similar Items